МОТОНЕЙРОН КАСАЛЛИГИДА НЕЙРОИММУНОЛОГИК ТАШХИС

##article.authors##

  • Рахимбаева Гулнора Саттаровна
  • Акбарова Саида Бахтиеровна
  • Равзатов Жасурбек Бахромович

##article.subject##:

: Мотонейрони касаллиги, ён амиотрофик склероз, миелин ассоцирланган гликопротеин (MAG)

##article.abstract##

Ён амиотрофик склероз (ЁАС), ўлимга олиб келадиган неврологик касаллик, шунингдек, Лу Герриг касаллиги сифатида ҳам танилган бўлиб, сурункали, аста-секин ривожланувчи хамда тана охирлари спастик-атрофик ва бульбар фалажликлар билан кечувчи марказий ва периферик мотонейрон зарарланиши натижасида юзага келадиган этакчи клиник синдромлардир. Ҳозирги вақтда спорадик ЁАС этиологияси тўлиқ ўрганилмаганига қарамай, беморларнинг 10-20% аутоиммун жараёнларга мойиллик мавжудлиги аниқланган.

Библиографические ссылки

Latov N. Antibodies t o glycoconjugates in neuropathy and motor-neuron disease. Proc Brain Res 1994;101:295–303.

Chassande B., Leger J.M., Younes- Chennoufi et al. Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve

;21:55–62.

Kornberg A.J., Pestronk A. Chronic motor neuropathies: diagnosis, therapy, and pathogenesis. Ann Neurol 1995;37 Suppl

:43–50.

Ilyas A.A., Quarles R.H., Dalakas M.C.

et al. Monoclonal IgM in patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol 1985;18:655–9.

Willison H.J., O’Learly, Veitch J. et al. The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain 2001;24:1968–77.

Ilyas A.A., Willison H.J., Quarles R.H.

et al. Serum antibodies to gangliosides in Guillain-Barre syndrome. Ann Neurol 1988;23:440–7.

Svennerholm L. Designation and schematic structure of gangliosides and allied glycosphingolipids. Prog Brain Res

;101:11–4.

Weller M., Stevens A., Sommer N. et al. Ganglioside antibodies: a lack of diagnostic specificity and clinical utility? J Neurol

;239:455–59.

Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900–2.

Chiba A., Kusunoki S., Obata H. et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911–7.

Gong Y., Lunn M.P., Heffer-Lauc M. et al. Localization of major gangliosides in the PNS: implications for immune neuropathies.

J Periph Nerv Syst 2001;6:42.

Corbo M., Quattrini A., Latov N., Hays A.P. Localisation of GM1 and Gal(beta1-3)GalNAc antigenic determinants in peripheral nerve. Neurology 1993;43:809–14.

O’Hanlon G.M., Paterson G.J., Veitch J. et al. Mapping immunoreactive epitopes in the the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies. Acta Neuropathol (Berl)

;95:605–16.

Zielasek J., Ritter G., Magi S. et al. A comparative trial of anti-glyoconjugate antibody assays: IgM antibodies to GM1. J Neurol 1994;241:475–80.

Willison H., Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591–625.

Загрузки

##submissions.published##

2024-01-05